No. 22-37
Title:Teva Pharmaceuticals USA, Inc., Petitioner
GlaxoSmithKline LLC, et al.
Docketed:July 13, 2022
Linked with 21A677
Lower Ct:United States Court of Appeals for the Federal Circuit
   Case Numbers:(2018-1976, 2018-2023)
   Decision Date:August 5, 2021
   Rehearing Denied:February 11, 2022
  Discretionary Court Decision Date:

DateProceedings and Orders
Apr 29 2022Application (21A677) to extend the time to file a petition for a writ of certiorari from May 12, 2022 to July 11, 2022, submitted to The Chief Justice.
Main DocumentLower Court Orders/OpinionsLower Court Orders/OpinionsLower Court Orders/Opinions
May 03 2022Application (21A677) granted by The Chief Justice extending the time to file until July 11, 2022.
Jul 11 2022Petition for a writ of certiorari filed. (Response due August 12, 2022)
PetitionAppendixCertificate of Word CountProof of Service
Jul 25 2022Motion to extend the time to file a response from August 12, 2022 to September 12, 2022, submitted to The Clerk.
Main Document
Jul 26 2022Motion to extend the time to file a response is granted and the time is extended to and including September 12, 2022.

Attorneys for Petitioner
William McGinley Jay
    Counsel of Record
Goodwin Procter, LLP
1900 N Street, N.W.
Washington, DC 20036
Party name: Teva Pharmaceuticals USA, Inc.
Attorneys for Respondents
Juanita R. Brooks
    Counsel of Record
Suite 3200
750 B Street
San Diego, CA 92101
Party name: GlaxoSmithKline LLC, et al.